Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy

Recent studies suggest that cancer stemness drives the acquired drug resistance process in cancer therapy. The complementary information provided by multi-omics data can help us to gain a deeper understanding of this process. This study aims to elucidate the impact of cancer stemness on the frontlin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Peng, Hu, Henglong, Lu, Yuchao, Xiao, Jun, Wang, Yanan, Xun, Yang, Xu, Jinzhou, Liu, Chenqian, Wang, Shaogang, Hu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633874/
https://www.ncbi.nlm.nih.gov/pubmed/36381657
http://dx.doi.org/10.1016/j.omto.2022.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633874/
https://www.ncbi.nlm.nih.gov/pubmed/36381657
http://dx.doi.org/10.1016/j.omto.2022.10.005

Ejemplares similares